Cargando…

Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey

BACKGROUND: A high seropositive rate of thyroid autoantibodies is often reported in patients with type 1 diabetes mellitus (T1DM), latent autoimmune diabetes in adults (LADA) and type 2 diabetes mellitus (T2DM). However, the positive rate of thyroid autoantibodies in latent autoimmune diabetes in yo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Xixi, Li, Xia, Xiang, Yufei, Yan, Xiang, Zhou, Houde, Tang, Xiaohan, Cheng, Jin, Niu, Xiaohong, Liu, Jing, Ji, Qiuhe, Ji, Linong, Huang, Gan, Zhou, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469127/
https://www.ncbi.nlm.nih.gov/pubmed/36111021
http://dx.doi.org/10.21037/atm-22-423
_version_ 1784788570972618752
author Nan, Xixi
Li, Xia
Xiang, Yufei
Yan, Xiang
Zhou, Houde
Tang, Xiaohan
Cheng, Jin
Niu, Xiaohong
Liu, Jing
Ji, Qiuhe
Ji, Linong
Huang, Gan
Zhou, Zhiguang
author_facet Nan, Xixi
Li, Xia
Xiang, Yufei
Yan, Xiang
Zhou, Houde
Tang, Xiaohan
Cheng, Jin
Niu, Xiaohong
Liu, Jing
Ji, Qiuhe
Ji, Linong
Huang, Gan
Zhou, Zhiguang
author_sort Nan, Xixi
collection PubMed
description BACKGROUND: A high seropositive rate of thyroid autoantibodies is often reported in patients with type 1 diabetes mellitus (T1DM), latent autoimmune diabetes in adults (LADA) and type 2 diabetes mellitus (T2DM). However, the positive rate of thyroid autoantibodies in latent autoimmune diabetes in youth (LADY) patients has not been reported in China. Thus, the purpose of the current study was to clarify the thyroid autoantibody distribution in patients with LADY to provide evidence for the clinical screening of autoimmune thyroid diseases (AITD). METHODS: This nationwide, multicenter and cross-sectional study included 1,723 younger patients (<30 years old) and 2,000 older patients (≥30 years old) aged 15 to 79 years. The patients were grouped into younger T1DM (n=281), LADY (n=130), younger T2DM (n=200), older T1DM (n=287), LADA (n=129), and older T2DM (n=200) groups. Autoantibodies against thyroid peroxidase (TPOA) and thyroglobulin (TGA) prevalence were analyzed in each group. RESULTS: The prevalence of TGA or TPOA in LADY patients was similar to that in younger T1DM patients. The seropositive rate of TPOA in LADY patients was higher than that in LADA patients (36.2% vs. 23.3%, respectively; P=0.023); the risk of TPOA was higher in LADY patients than in LADA patients, even after adjusting for sex, glutamic acid decarboxylase (GADA)- and insulinoma-associated-2 (IA-2A)-positivity (OR =1.94, P=0.023). LADY patients with high GADA titers exhibited a higher frequency of thyroid autoantibodies than patients with low GADA titers did (TPOA, P=0.005; TGA, P=0.023; TPOA or TGA, P=0.004). Further analysis showed that only male patients showed a strong association between high GADA titers and thyroid autoantibodies positivity, and the association remained significant after adjustment for age (OR =11.14, P=0.025 for TGA; OR =4.99, P=0.011 for TPOA; OR =5.52, P=0.007 for TPOA or TGA). CONCLUSIONS: Routine screening for thyroid autoantibodies is recommended in LADY patients, and special clinical attention should be paid to the thyroid autoantibodies status of male patients of LADY with high GADA titers to identify patients at high risk of developing AITD.
format Online
Article
Text
id pubmed-9469127
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-94691272022-09-14 Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey Nan, Xixi Li, Xia Xiang, Yufei Yan, Xiang Zhou, Houde Tang, Xiaohan Cheng, Jin Niu, Xiaohong Liu, Jing Ji, Qiuhe Ji, Linong Huang, Gan Zhou, Zhiguang Ann Transl Med Original Article BACKGROUND: A high seropositive rate of thyroid autoantibodies is often reported in patients with type 1 diabetes mellitus (T1DM), latent autoimmune diabetes in adults (LADA) and type 2 diabetes mellitus (T2DM). However, the positive rate of thyroid autoantibodies in latent autoimmune diabetes in youth (LADY) patients has not been reported in China. Thus, the purpose of the current study was to clarify the thyroid autoantibody distribution in patients with LADY to provide evidence for the clinical screening of autoimmune thyroid diseases (AITD). METHODS: This nationwide, multicenter and cross-sectional study included 1,723 younger patients (<30 years old) and 2,000 older patients (≥30 years old) aged 15 to 79 years. The patients were grouped into younger T1DM (n=281), LADY (n=130), younger T2DM (n=200), older T1DM (n=287), LADA (n=129), and older T2DM (n=200) groups. Autoantibodies against thyroid peroxidase (TPOA) and thyroglobulin (TGA) prevalence were analyzed in each group. RESULTS: The prevalence of TGA or TPOA in LADY patients was similar to that in younger T1DM patients. The seropositive rate of TPOA in LADY patients was higher than that in LADA patients (36.2% vs. 23.3%, respectively; P=0.023); the risk of TPOA was higher in LADY patients than in LADA patients, even after adjusting for sex, glutamic acid decarboxylase (GADA)- and insulinoma-associated-2 (IA-2A)-positivity (OR =1.94, P=0.023). LADY patients with high GADA titers exhibited a higher frequency of thyroid autoantibodies than patients with low GADA titers did (TPOA, P=0.005; TGA, P=0.023; TPOA or TGA, P=0.004). Further analysis showed that only male patients showed a strong association between high GADA titers and thyroid autoantibodies positivity, and the association remained significant after adjustment for age (OR =11.14, P=0.025 for TGA; OR =4.99, P=0.011 for TPOA; OR =5.52, P=0.007 for TPOA or TGA). CONCLUSIONS: Routine screening for thyroid autoantibodies is recommended in LADY patients, and special clinical attention should be paid to the thyroid autoantibodies status of male patients of LADY with high GADA titers to identify patients at high risk of developing AITD. AME Publishing Company 2022-08 /pmc/articles/PMC9469127/ /pubmed/36111021 http://dx.doi.org/10.21037/atm-22-423 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Nan, Xixi
Li, Xia
Xiang, Yufei
Yan, Xiang
Zhou, Houde
Tang, Xiaohan
Cheng, Jin
Niu, Xiaohong
Liu, Jing
Ji, Qiuhe
Ji, Linong
Huang, Gan
Zhou, Zhiguang
Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey
title Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey
title_full Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey
title_fullStr Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey
title_full_unstemmed Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey
title_short Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey
title_sort thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469127/
https://www.ncbi.nlm.nih.gov/pubmed/36111021
http://dx.doi.org/10.21037/atm-22-423
work_keys_str_mv AT nanxixi thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT lixia thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT xiangyufei thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT yanxiang thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT zhouhoude thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT tangxiaohan thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT chengjin thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT niuxiaohong thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT liujing thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT jiqiuhe thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT jilinong thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT huanggan thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey
AT zhouzhiguang thyroidautoantibodydistributioninpatientswithlatentautoimmunediabetesinyouthamulticenternationalsurvey